What investment strategy does Verto focus on?

Verto focuses on Growth, Buyout strategies in the private equity space.

How many portfolio companies does Verto have?

Verto has 10 active portfolio companies and 5 completed exits and 2 funds tracked on GP Intel.

Where is Verto headquartered?

Verto is headquartered in Paris, France.

What is Verto's assets under management?

Verto manages approximately €470M in assets under management.

What sectors does Verto invest in?

Verto invests across Software, Healthcare.

What are Verto's recent exits?

Recent realized exits by Verto include: CHR Group (2026) to PSG Equity; BioBank (2024) to IK Partners; Presto Engineering (2024) to Dentressangle Capital; OMP Transport (2023) to Bridgepoint Development Capital; Sinari Group (2023) to Bridgepoint Development Capital.

Home/GPs/Verto

DetailCard

Verto

Paris, France·Founded 2016·

Growth Equity Buyout

·vertogrowth.com

Paris-based independent growth and buyout PE firm founded 2016 by Antoine Dary, specializing in B2B Software and HealthTech investments across France, Benelux and Switzerland with EUR 15-60M tickets. Manages around EUR 470M across Verto Growth I (2020 EUR 140M Harvesting) and Verto Growth II (2025 EUR 330M final close July 2025 hard cap, Investing); notable exits BioBank August 2024 to IK Partners and Presto Engineering 2024 to Dentressangle Capital.

AUM

€470M

Funds

vintages 2020–2025

Portfolio

Exits

Verto is a Paris growth equity firm with €470M AUM, 10 active companies and 5 exits.

SectorsSoftware Healthcare

Key takeaways

·5 exits in the last 5 years · consistent DPI cadence.
·Average hold across 5 realized deals: 5 years.
·Top sector focus: TMT (47% of portfolio).
·Fund cadence: ~5Y between vintages · last raise 2025.

Sector breakdown

15 companies

TMT

7 · 47%

SaaS

1 · 7%

Cybersecurity

1 · 7%

Biotech

1 · 7%

HealthTech

1 · 7%

HR Tech

1 · 7%

Healthcare

1 · 7%

Industrials

1 · 7%

Key facts

HQParis, France

Founded2016

Websitevertogrowth.com

Recent exits

Verto sold CHR Group to PSG Equity in 2026 after 6 years.

Verto sold BioBank to IK Partners in 2024 after 9 years.

Verto sold Presto Engineering to Dentressangle Capital in 2024 after 6 years.

Verto sold OMP Transport to Bridgepoint Development Capital in 2023 after 4 years.

Coverage notes

2 funds tracked, 15 portfolio companies (10 active · 5 realized). Verified weekly from public filings and deal announcements.

Funds & portfolio

Every fund Verto has raised, with its portfolio companies. Hand-checked from public filings.

2 funds

Fund

Strategy

Vintage

Size

Assets

Exits

Verto Growth II

Growth2025€330M4 assets

Growth

2025 · 1yr

€330M

–

Unrealized

4 held

Company	Entry
Club Employes SaaS · France	2025
Iskera TMT · France	2025
Mailinblack Cybersecurity · France	2022
MyTower TMT · France	2025

Verto Growth IHarvesting

Growth2020€140M6 assets5 exits

Growth

2020 · 6yr

€140M

Unrealized

6 held

Company	Entry
CBA HealthTech · France	2019
Club Employés HR Tech · France	2021
DQE Software TMT · France	2021
Elap Healthcare · France	2022
GAC Software TMT · France	2020
Lessonia Industrials · France	2018

Realized

5 exits

Company	Entry	Exit	Type	Buyer	MOIC
BioBank Biotech · France	2015	2024	Secondary	IK Partners	–
CHR Group TMT · France	2020	2026	Secondary	PSG Equity	–
OMP Transport TMT · France	2019	2023	Secondary	Bridgepoint Development Capital	–
Presto Engineering Deep Tech · France	2018	2024	Secondary	Dentressangle Capital	–
Sinari Group TMT · France	2021	2023	Secondary	Bridgepoint Development Capital	–

About Verto

Verto is a Paris-based independent growth and buyout private equity firm with €470 million of assets under management, founded in 2016 by Antoine Dary. The firm specialises in B2B Software and HealthTech investments across France, Benelux and Switzerland, deploying capital across Verto Growth I and II vintage funds with equity tickets ranging from €15 million to €60 million per transaction.

Investment thesis

Verto targets European B2B Software and HealthTech companies at growth equity and selective buyout stages, with sector focus on enterprise software, vertical SaaS, healthcare technology and selective fintech verticals. The pan-European mandate covering France, Benelux and Switzerland provides distinctive deal flow across French-speaking and DACH-adjacent European tech markets. Equity ticket sizes enable Verto to participate in scaling rounds for profitable European tech companies.

Recent activity

Recent realised exits include BioBank (healthcare, 2024) and Presto Engineering (industrials, 2024), reflecting active distribution across the B2B technology portfolio. The platform tracks 2 funds and 11 active portfolio companies across the multi-vintage European tech programme.

Frequently asked questions

What investment strategy does Verto focus on?: Verto focuses on Growth, Buyout strategies in the private equity space.
How many portfolio companies does Verto have?: Verto has 10 active portfolio companies and 5 completed exits and 2 funds tracked on GP Intel.
Where is Verto headquartered?: Verto is headquartered in Paris, France.
What is Verto's assets under management?: Verto manages approximately €470M in assets under management.
When was Verto founded?: Verto was founded in 2016.
What sectors does Verto invest in?: Verto invests across Software, Healthcare.
What are Verto's recent exits?: Recent realized exits by Verto include: CHR Group (2026) to PSG Equity; BioBank (2024) to IK Partners; Presto Engineering (2024) to Dentressangle Capital; OMP Transport (2023) to Bridgepoint Development Capital; Sinari Group (2023) to Bridgepoint Development Capital.